Loading
Mariana Chavez-MacGregor is a breast oncologist who studies how care is delivered and leads SWOG's international work.
Mariana Chavez-MacGregor is Professor of Breast Medical Oncology and Health Services Research at MD Anderson Cancer Center and SWOG Executive Officer for International Affairs. A medical oncologist and health services researcher, she studies treatment timing, disparities and outcomes in breast cancer and how care is delivered. Her papers include a JAMA Oncology study of delayed initiation of adjuvant chemotherapy among patients with breast cancer and a JAMA Oncology evaluation of COVID-19 outcomes in US patients with or without cancer. She leads SWOG's international work within the SWOG Cancer Research Network, with a focus on triple-negative and HR-positive breast cancer and cooperative group trials.
| Title | Journal | Year |
|---|---|---|
| Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer | JAMA Oncology | 2016 |
| Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer | JAMA Oncology | 2022 |
Shares SWOG Cancer Research Network, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
Shares MD Anderson Cancer Center, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
Shares MD Anderson Cancer Center, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
Shares SWOG Cancer Research Network, HR-positive / HER2-negative breast cancer.
Shares MD Anderson Cancer Center, Triple-negative breast cancer (TNBC).
Shares MD Anderson Cancer Center, HR-positive / HER2-negative breast cancer.
Shares MD Anderson Cancer Center, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
Shares MD Anderson Cancer Center, HR-positive / HER2-negative breast cancer.